Federal Courts Where We Have Litigated Patent Cases
Our team has litigated over 100 patent cases across the U.S., including in top venues known for high-stakes intellectual property litigation. We have represented clients in federal district courts such as the:
- Eastern District of Texas
- District of Delaware
- Southern District of New York
- District of New Jersey
- Northern District of California
- Central District of California
- Southern District of California
- Eastern District of Virginia
- Western District of Virginia
- District of South Carolina
- Northern District of Georgia
- Middle District of Georgia
- Eastern District of North Carolina
- Middle District of North Carolina
- Western District of North Carolina
- Northern District of Illinois
- Eastern District of Pennsylvania
We also have significant experience representing clients before the U.S. Court of Appeals for the Federal Circuit.
Selected Patent Litigation Experience
District Court & Federal Circuit Patent Litigation
- Defended power tool distributor in patent infringement cases in the Eastern District of Texas, achieving favorable settlement after bringing patentee to the table via a strategic motion for summary judgment.
- Represented a global auto manufacturer in a patent dispute before the Eastern District of Virginia involving GPS devices.
- Defended a packaged foods company in the Southern District of California and on appeal before the Federal Circuit, which ultimately found no patent infringement.
- Secured a motion to dismiss claims involving a guitar video game before the Eastern District of North Carolina based on patent eligibility; ruling was upheld on appeal before the Federal Circuit.
- Represented recreation equipment manufacturer in patent and trademark case; secured a consent injunction for willful patent infringements and other remedies on the eve of trial after two years of litigation.
- Secured summary judgment of patent infringement and patent claim validity against a copycat competitor.
- Represented a multinational company accused of patent infringement and secured a positive resolution after discovery uncovered flaws in the plaintiffs' case.
- Defended an innovative client accused of patent infringement in which the plaintiff voluntarily dismissed the case after two years of litigation to avoid risking a ruling on summary judgment.
- Represented power tool manufacturer in patent case; successfully negotiated advantageous settlement after discovering patent marking failure by patent owner.
- Represented a plaintiff against a patent infringer and achieved beneficial settlement terms despite claims of patent invalidity.
- Defended an office equipment manufacturer in the Central District of California and Eastern District of Pennsylvania as part of a dual strategy before the USPTO that involved invalidating patent claims and wiping out millions of dollars in damages through ex parte reexaminations.
- Represented a fence manufacturer in the Northern District of Georgia in a patent design-around strategy that resulted in a favorable settlement.
- Defended a furniture manufacturer in the District of South Carolina against patent, trademark, and copyright claims; invalidated one of the plaintiff’s patents and settled on favorable terms.
PTAB & Post-Grant Proceedings
- Represented a Fortune 100 software-industrial company in an inter partes review (IPR) proceeding before the PTAB involving patents related to an energy management system and method.
- Represented defendants in an action for patent infringement, where the court found that our client did not infringe the asserted claims of the patent-in-suit and, as part of a two-part strategy, obtained a ruling before the PTAB that the claims of the patent-in-suit were unpatentable. The Federal Circuit affirmed the PTAB’s finding of unpatentability.
ANDA & Pharmaceutical Patent Litigation
- Represented generic pharmaceutical company in multiple Abbreviated New Drug Application (ANDA) cases in federal district courts in Delaware, New York, New Jersey, West Virginia, and South Carolina; negotiated settlement terms cutting off the exclusivity period of the holder of a New Drug Application (NDA).
- Prevailed before the Federal Circuit on motion for judgment on the pleadings demonstrating that our client’s generic pharmaceutical drug did not infringe on the sole remaining asserted patent covering a branded product with annual U.S. sales exceeding $3 billion. The case involved a successful defense of our client’s 505(b)(2) application.
- Represented and filed an amicus brief for a generic pharmaceutical manufacturers’ association before the Federal Circuit. This case principally involved issues concerning alleged inducement of infringement in a dispute about patents on a drug used to treat epilepsy and neurodegenerative diseases. The Court of Appeals decided the case on terms favorable to our client.